Mfazo Hove was diagnosed with acute anterior uveitis, followed by cataracts, and feared he could ‘lose (his) sight’.

Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food and Drug ...

The US Food and Drug Administration (FDA) has cleared Novaliq’s Investigational New Drug (IND) application for NOV05, enabling the initiation of the EYETAC phase II clinical trial ( NCT07285070) in ...

The FDA cleared an investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious ...

NICKI Guy was living the dream on a beautiful Caribbean island with her husband and young son when, peering into the mirror, ...

Difluprednate ophthalmic emulsion is indicated for the treatment of inflammation and pain associated with ocular surgery and also indicated for the treatment of endogenous anterior uveitis.

The Monongalia County Commission on Wednesday approved a resolution authorizing participation in a master lease-sublease agreement in support of Trinity Christian School. The agreement will allow the ...

Alembic Pharmaceuticals Ltd received final approval from the USFDA for its generic Difluprednate ophthalmic emulsion, used to ...

Orange, Calif.-based UCI Health has opened an outpatient center in Brea, Calif.  The Brea Outpatient Center will expand patient access to ophthalmologists from the UCI Health Gavin Herbert Eye ...

Alembic Pharmaceuticals said it has received final US FDA approval for its Difluprednate ophthalmic emulsion, expanding its ...

Alembic Pharmaceuticals Ltd on Tuesday said it has received final approval from the US health regulator for its generic version of Difluprednate ophthalmic emulsion used to treat eye inflammation and ...

The approved ANDA is therapeutically equivalent to the reference listed drug product, Durezol ophthalmic emulsion, 0.05% of ...